Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Other Operating Expenses (2017)

Monopar Therapeutics (MNPR) has disclosed Other Operating Expenses for 1 consecutive years, with $14.5 million as the latest value for Q3 2017.

  • Quarterly Other Operating Expenses changed N/A to $14.5 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $14.5 million through Jun 2018, changed N/A year-over-year, with the annual reading at $14.5 million for FY2017, N/A changed from the prior year.
  • Other Operating Expenses hit $14.5 million in Q3 2017 for Monopar Therapeutics.
  • In the past five years, Other Operating Expenses ranged from a high of $14.5 million in Q3 2017 to a low of $14.5 million in Q3 2017.